TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma

Lesleyann Hawthorn, Leighton Stein, Ram Varma, Samuel Wiseman, Thom Loree, Dong Feng Tan

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background. No molecular pathways or specific genes are consistently associated with sporadic cases of papillary thyroid carcinoma (PTC), despite that it is the most common thyroid malignancy. Nodular goiter is an enlargement of the thyroid that is a compensatory response to a perturbation in normal thyroid homeostasis. It has been disputed in the literature that patients presenting with goiter have a higher incidence of PTC. The identification of molecular events that are common to both goiter and PTC could explain the overlap of these two disorders. Methods. We used high-density oligonuleotide arrays to perform molecular profiling of PTC and nodular goiter with paired normal samples. Results. Specifically, increased expression of SERPIN-A (proteinase inhibitor-alpha antitrypsin) and TIMP 1 (tissue inhibitor of metalloproteinase 1) identified these as candidate molecular biomarkers for PTC. Decreases in the CRABP1 (cellular retinoic acid binding protein 1) and TFF3 (trefoil factor 3) expression levels identified these as candidate molecular biomarkers as well. The same analysis was performed to identify genes showing specific alterations in goiter tissues. Conclusions. This is the first report to our knowledge that compares the gene expression profiles of PTC and goiter. Our results suggest that PTC and goiter share very limited overlap in transcript expression.

Original languageEnglish (US)
Pages (from-to)1069-1083
Number of pages15
JournalHead and Neck
Volume26
Issue number12
DOIs
StatePublished - Dec 1 2004

Fingerprint

Retinoic Acid Receptors
Goiter
Biomarkers
Nodular Goiter
Thyroid Gland
Tissue Inhibitor of Metalloproteinase-1
Trefoil Factor-3
Papillary Thyroid cancer
Transcriptome
Genes
Homeostasis
Peptide Hydrolases
Incidence

Keywords

  • Gene expression alterations
  • Goiter
  • Microarray
  • Papillary thyroid carcinoma

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma. / Hawthorn, Lesleyann; Stein, Leighton; Varma, Ram; Wiseman, Samuel; Loree, Thom; Tan, Dong Feng.

In: Head and Neck, Vol. 26, No. 12, 01.12.2004, p. 1069-1083.

Research output: Contribution to journalArticle

Hawthorn, Lesleyann ; Stein, Leighton ; Varma, Ram ; Wiseman, Samuel ; Loree, Thom ; Tan, Dong Feng. / TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma. In: Head and Neck. 2004 ; Vol. 26, No. 12. pp. 1069-1083.
@article{e24d3d73295044f1a63317bfec743ce0,
title = "TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma",
abstract = "Background. No molecular pathways or specific genes are consistently associated with sporadic cases of papillary thyroid carcinoma (PTC), despite that it is the most common thyroid malignancy. Nodular goiter is an enlargement of the thyroid that is a compensatory response to a perturbation in normal thyroid homeostasis. It has been disputed in the literature that patients presenting with goiter have a higher incidence of PTC. The identification of molecular events that are common to both goiter and PTC could explain the overlap of these two disorders. Methods. We used high-density oligonuleotide arrays to perform molecular profiling of PTC and nodular goiter with paired normal samples. Results. Specifically, increased expression of SERPIN-A (proteinase inhibitor-alpha antitrypsin) and TIMP 1 (tissue inhibitor of metalloproteinase 1) identified these as candidate molecular biomarkers for PTC. Decreases in the CRABP1 (cellular retinoic acid binding protein 1) and TFF3 (trefoil factor 3) expression levels identified these as candidate molecular biomarkers as well. The same analysis was performed to identify genes showing specific alterations in goiter tissues. Conclusions. This is the first report to our knowledge that compares the gene expression profiles of PTC and goiter. Our results suggest that PTC and goiter share very limited overlap in transcript expression.",
keywords = "Gene expression alterations, Goiter, Microarray, Papillary thyroid carcinoma",
author = "Lesleyann Hawthorn and Leighton Stein and Ram Varma and Samuel Wiseman and Thom Loree and Tan, {Dong Feng}",
year = "2004",
month = "12",
day = "1",
doi = "10.1002/hed.20099",
language = "English (US)",
volume = "26",
pages = "1069--1083",
journal = "Head and Neck Surgery",
issn = "0148-6403",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma

AU - Hawthorn, Lesleyann

AU - Stein, Leighton

AU - Varma, Ram

AU - Wiseman, Samuel

AU - Loree, Thom

AU - Tan, Dong Feng

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Background. No molecular pathways or specific genes are consistently associated with sporadic cases of papillary thyroid carcinoma (PTC), despite that it is the most common thyroid malignancy. Nodular goiter is an enlargement of the thyroid that is a compensatory response to a perturbation in normal thyroid homeostasis. It has been disputed in the literature that patients presenting with goiter have a higher incidence of PTC. The identification of molecular events that are common to both goiter and PTC could explain the overlap of these two disorders. Methods. We used high-density oligonuleotide arrays to perform molecular profiling of PTC and nodular goiter with paired normal samples. Results. Specifically, increased expression of SERPIN-A (proteinase inhibitor-alpha antitrypsin) and TIMP 1 (tissue inhibitor of metalloproteinase 1) identified these as candidate molecular biomarkers for PTC. Decreases in the CRABP1 (cellular retinoic acid binding protein 1) and TFF3 (trefoil factor 3) expression levels identified these as candidate molecular biomarkers as well. The same analysis was performed to identify genes showing specific alterations in goiter tissues. Conclusions. This is the first report to our knowledge that compares the gene expression profiles of PTC and goiter. Our results suggest that PTC and goiter share very limited overlap in transcript expression.

AB - Background. No molecular pathways or specific genes are consistently associated with sporadic cases of papillary thyroid carcinoma (PTC), despite that it is the most common thyroid malignancy. Nodular goiter is an enlargement of the thyroid that is a compensatory response to a perturbation in normal thyroid homeostasis. It has been disputed in the literature that patients presenting with goiter have a higher incidence of PTC. The identification of molecular events that are common to both goiter and PTC could explain the overlap of these two disorders. Methods. We used high-density oligonuleotide arrays to perform molecular profiling of PTC and nodular goiter with paired normal samples. Results. Specifically, increased expression of SERPIN-A (proteinase inhibitor-alpha antitrypsin) and TIMP 1 (tissue inhibitor of metalloproteinase 1) identified these as candidate molecular biomarkers for PTC. Decreases in the CRABP1 (cellular retinoic acid binding protein 1) and TFF3 (trefoil factor 3) expression levels identified these as candidate molecular biomarkers as well. The same analysis was performed to identify genes showing specific alterations in goiter tissues. Conclusions. This is the first report to our knowledge that compares the gene expression profiles of PTC and goiter. Our results suggest that PTC and goiter share very limited overlap in transcript expression.

KW - Gene expression alterations

KW - Goiter

KW - Microarray

KW - Papillary thyroid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=10044254396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044254396&partnerID=8YFLogxK

U2 - 10.1002/hed.20099

DO - 10.1002/hed.20099

M3 - Article

C2 - 15515157

AN - SCOPUS:10044254396

VL - 26

SP - 1069

EP - 1083

JO - Head and Neck Surgery

JF - Head and Neck Surgery

SN - 0148-6403

IS - 12

ER -